340B Insight Podcast
340B Insight is 340B Health’s podcast, providing our members and supporters with timely news updates and discussion around the 340B drug pricing program. The podcast enables listeners to stay current and expand their knowledge of 340B to help them serve their patients and communities and remain compliant with rules and requirements. New episodes are published twice per month and include news update segments and in-depth interviews with leading experts including health care practitioners, policy and legal experts, public policymakers, and our expert staff.
Have a question or suggestion for 340B Insight? Email us at: podcast@340bhealth.org
Podcast sponsorship opportunities are available. Email to learn more: robin.hayes@340bhealth.org
Follow 340B Health on Twitter, Facebook, and LinkedIn
Episodes
-
Episode 71: A Hospital CEO’s Advice for 340B Professionals
340B helps health systems and hospitals stretch their resources and provide more services to patients in need. This makes 340B important to a hospital or health system leadership team’s ability to plan how it will deliver care. In this episode, we speak with Matthew Perry, president and CEO of Genesis Healthcare System in Zanesville, Ohio. Matt shares his perspective about 340B and how 340B professionals can best engage with their hospital CEO. Prior to the interview, we share findings from a new 340B Health report about the effects of drug company 340B contract pharmacy restrictions on patient care. (Transcript)
Read more -
Episode 70: 340B Internal Audits
340B compliance is a critical requirement for hospitals participating in the program, and one of the ways 340B hospitals maintain compliance is through conducting internal audits. For this episode, we speak with Tristan Greer, 340B program business manager at Catholic Health in Buffalo, N.Y. Tristan has significant experience conducting 340B internal audits at the health system, and she shares several best practices for a successful internal audit. Before the interview, we provide a news update on how drug manufacturers are pursuing legislative changes to 340B and some of the responses to that proposal. (Transcript)
Read more -
Episode 69: How One State Protected 340B
State policymakers have increased the attention they are paying to 340B. In this episode, we hear from 340B state advocacy expert Abby Reale. Abby is director of government and external affairs with Mountain Health Network in West Virginia. The state has been a leader in protecting 340B, and she shares how her health system worked with other hospitals and provider organizations to advocate for the first 340B non-discrimination law in the nation. Prior to the interview, we provide a news update about a drug company that is imposing the pharmaceutical industry’s most restrictive limits on 340B pricing. (Transcript)
Read more -
Episode 68: Making Health IT Work With 340B
Health information technology (IT) is intertwined with 340B operations and compliance. So how can hospitals and health systems manage IT while keeping 340B in mind? To find out, we hear from Robert Owens, director of pharmacy enterprise shared services at Atrium Health. Bob is a pharmacy health IT expert, and he shares how the technology intersects with 340B. He also shares insights to ensure strong 340B operations and compliance when undergoing an electronic health records (EHR) system conversion. Before the interview, we provide an update on two more drug companies restricting 340B discounts. (Transcript)
Read more -
Episode 67: Maureen Testoni’s Outlook for 340B in 2023
Several 340B developments have occurred in the first weeks of 2023, with many more expected to come this year. In this episode, we speak with 340B Health President and CEO Maureen Testoni about her outlook for 340B. Our discussion includes her analysis of the latest in the 340B contract pharmacy dispute, the 340B advocacy landscape at the federal and state levels, and Medicare issues affecting 340B.
*Editor’s note: We spoke with Maureen prior to Bayer and EMD Serono announcing they will restrict 340B discounts. When these restrictions start in March, at least 21 companies will be limiting 340B discounts, with 14 of these companies conditioning 340B pricing on providers sharing contract pharmacy claims data.* (Transcript)
Read more -
Episode 66: Your 340B Questions Answered
We often receive listener questions about 340B issues and developments that affect professionals in the 340B world. In this episode, we open the listener virtual mailbag and answer some of your questions with help from our 340B Health staff experts. Some of the questions we tackle include queries about mitigating 340B contract pharmacy restrictions, understanding 340B patient definition, analyzing current 340B hospital audit trends, and examining Medicare Advantage payment rates for 340B drugs. (Transcript)
Read more